| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $92.0M | +17.5% |
| Cost of Revenue | $24.5M | +27.4% |
| Gross Profit | $67.4M | +14.2% |
| R&D Expense | $24.4M | +36.0% |
| SG&A Expense | $11.4M | +47.4% |
| Operating Income | -$2.1M | -129.1% |
| Pre-tax Income | -$1.2M | -117.8% |
| Income Tax | $1.2M | +844.0% |
| Net Income | -$2.4M |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $72.2M | +14.1% |
| Accounts Receivable | $27.0M | +2.5% |
| Current Assets | $104.1M | +10.0% |
| Total Assets | $126.0M | +10.0% |
| Current Liabilities | $62.0M | -2.4% |
| Total Liabilities | $69.2M | +0.9% |
| Stockholders' Equity | $56.9M | +23.4% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.1M | -41.4% |
| Capital Expenditures | $628K | +56.2% |
| Investing Cash Flow | -$628K | -56.2% |
| Financing Cash Flow | $3.3M | +41.5% |
| Free Cash Flow | $7.5M | -44.3% |
| -135.1% |
| EPS (Basic) | -$0.08 | -136.4% |
| EPS (Diluted) | -$0.08 | -138.1% |